We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazine Derivatives
News

Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazine Derivatives

Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazine Derivatives
News

Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazine Derivatives

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazine Derivatives"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Abstract
A series of novel 1,3,4-thiadiazine derivatives were synthesized via chemical optimization on phthiobuzone. Their anti-herpes simplex virus (HSV) activities in vitro were also tested. Several compounds exhibited more highly potent anti-HSV activity and much higher selectivity index (SI) values than those of phthiobuzone. The most potent anti-HSV compound was 4f, which showed marked inhibition against HSV-1 (IC(50)=77.04 µg/ml) and HSV-2 (IC(50)=30.00 µg/ml). Meanwhile it had low cytotoxicity (CC(50)=1000.00 µg/ml), resulting in high (SI(HSV-1)=12.98, SI(HSV-2)=33.33, respectively). Furthermore, a computational study for prediction of absorption, distribution, metabolism, excretion (ADME) properties of compound 4f was performed by determination of topological polar surface area, absorption and Lipinski parameters.

The article is published online in Chemical & Pharmaceutical Bulletin and is free to access.

Advertisement